Showing results (41-50 of 47) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Bioorganic & Medicinal Chemistry Letters|April 18, 2022
Discovery and preclinical profile of LX-039, a novel indole-based oral selective estrogen receptor degrader (SERD)Jianyu Lu, Chi-Chung Chan, Deheng Sun, et al.Cancer|May 16, 2019
Oral arsenic trioxide incorporation into frontline treatment with all-trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5-year prospective studyHarinder Gill, Cyrus R Kumana, Rita Yim, et al.BMC Genetics|December 21, 2014
Genetic association between germline JAK2 polymorphisms and myeloproliferative neoplasms in Hong Kong Chinese population: a case-control studySu Pin Koh, Shea Ping Yip, Kwok Kuen Lee, et al.Diabetes|September 28, 2005
Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9George R Lankas, Barbara Leiting, Ranabir Sinha Roy, et al.Journal of Medicinal Chemistry|June 14, 2011
Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemiaRenata M Oballa, Liette Belair, W Cameron Black, et al.Bioorganic & Medicinal Chemistry Letters|September 20, 2005
Discovery of a substituted 8-arylquinoline series of PDE4 inhibitors: structure-activity relationship, optimization, and identification of a highly potent, well tolerated, PDE4 inhibitorDwight Macdonald, Anthony Mastracchio, Hélène Perrier, et al.Cancer Medicine|March 19, 2020
Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantationHarinder Gill, Rita Yim, Herbert H Pang, et al.Pageof 5